Smith & Nephew SNATS Operating Income 2010-2024 | SNN

Smith & Nephew SNATS annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Smith & Nephew SNATS operating income for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Smith & Nephew SNATS operating income for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Smith & Nephew SNATS annual operating income for 2024 was $0.657B, a 54.59% increase from 2023.
  • Smith & Nephew SNATS annual operating income for 2023 was $0.425B, a 5.56% decline from 2022.
  • Smith & Nephew SNATS annual operating income for 2022 was $0.45B, a 24.11% decline from 2021.
Smith & Nephew SNATS Annual Operating Income
(Millions of US $)
2024 $657
2023 $425
2022 $450
2021 $593
2020 $295
2019 $815
2018 $863
2017 $934
2016 $801
2015 $628
2014 $749
2013 $810
2012 $846
2011 $862
2010 $920
2009 $723
Smith & Nephew SNATS Quarterly Operating Income
(Millions of US $)
2024-12-31
2024-06-30
2023-12-31
2023-06-30
2022-12-31
2022-06-30
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2019-06-30
2018-12-31
2018-06-30
2017-12-31
2017-06-30
2016-12-31
2015-12-31
2015-06-30
2014-12-31 $226
2014-09-30 $160
2014-06-30 $134
2014-03-31 $229
2013-12-31 $235
2013-09-30 $180
2013-06-30 $188
2013-03-31 $207
2012-12-31 $213
2012-09-30 $187
2012-06-30 $210
2012-03-31 $236
2011-12-31 $214
2011-09-30 $191
2011-06-30 $226
2011-03-31 $231
2010-12-31 $267
2010-09-30 $206
2010-06-30 $207
2010-03-31 $240
2009-12-31 $189
2009-09-30 $186
2009-06-30 $189
2009-03-31 $159
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $13.236B $5.810B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $233.799B 28.11
Boston Scientific (BSX) United States $157.605B 39.46
Stryker (SYK) United States $150.214B 31.41
EssilorLuxottica (ESLOY) France $126.765B 0.00
Medtronic (MDT) Ireland $110.324B 15.64
Lonza Group Ag (LZAGY) Switzerland $50.804B 0.00
Haleon (HLN) United Kingdom $46.650B 26.61
ResMed (RMD) United States $37.413B 28.10
GE HealthCare Technologies (GEHC) United States $34.057B 16.17
Agilent Technologies (A) United States $33.852B 22.07
Terumo (TRUMY) Japan $27.835B 36.15
Koninklijke Philips (PHG) Netherlands $23.245B 16.31
Insulet (PODD) United States $22.033B 86.49
Zimmer Biomet Holdings (ZBH) United States $18.095B 11.62
Baxter (BAX) United States $15.595B 11.64
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.639B 23.10
Lantheus Holdings (LNTH) United States $5.638B 14.22
Prestige Consumer Healthcare (PBH) United States $3.998B 17.86
Perrigo (PRGO) Ireland $3.649B 9.25
Haemonetics (HAE) United States $3.545B 16.15
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.334B 27.70
ICU Medical (ICUI) United States $3.244B 23.92
GN Store Nord (GNNDY) Denmark $2.307B 19.11
QuidelOrtho (QDEL) United States $1.952B 13.43
LeMaitre Vascular (LMAT) United States $1.866B 41.70
AtriCure (ATRC) United States $1.598B 0.00
AdaptHealth (AHCO) United States $1.289B 13.08
Acuren (TIC) United States $1.271B 0.00
Green Thumb Industries (GTBIF) United States $1.111B 25.00
Phibro Animal Health (PAHC) United States $1.040B 13.30
Neogen (NEOG) United States $1.027B 13.14
BioLife Solutions (BLFS) United States $1.021B 0.00
Kestra Medical Technologies (KMTS) United States $0.907B 0.00
InMode (INMD) Israel $0.897B 9.04
Owens & Minor (OMI) United States $0.685B 5.69
CeriBell (CBLL) United States $0.683B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.629B 0.00
Evolus (EOLS) United States $0.589B 0.00
Curaleaf Holdings (CURLF) Canada $0.531B 0.00
Capricor Therapeutics (CAPR) United States $0.509B 0.00
Valneva SE (VALN) France $0.494B 0.00
Surmodics (SRDX) United States $0.412B 0.00
Tilray Brands (TLRY) Canada $0.403B 0.00
VAREX IMAGING (VREX) United States $0.354B 13.00
Quanterix (QTRX) United States $0.332B 0.00
SNDL (SNDL) Canada $0.323B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.301B 0.00
Viemed Healthcare (VMD) United States $0.274B 23.07
Cerus (CERS) United States $0.271B 0.00
ZimVie (ZIMV) United States $0.258B 11.72
Sanuwave Health (SNWV) United States $0.256B 0.00
Sanara MedTech (SMTI) United States $0.253B 0.00
Brainsway (BWAY) Israel $0.250B 66.10
Cresco Labs (CRLBF) United States $0.246B 0.00
Aurora Cannabis (ACB) Canada $0.233B 69.17
Biote (BTMD) United States $0.230B 6.46
OraSure Technologies (OSUR) United States $0.225B 0.00
Canopy Growth (CGC) Canada $0.224B 0.00
TriSalus Life Sciences (TLSI) United States $0.201B 0.00
Utah Medical Products (UTMD) United States $0.188B 15.29
Omeros (OMER) United States $0.188B 0.00
High Tide (HITI) Canada $0.184B 0.00
Organigram Global (OGI) Canada $0.181B 0.00
Verano Holdings (VRNOF) United States $0.177B 0.00
Exagen (XGN) United States $0.149B 0.00
Vireo Growth (VREOF) United States $0.144B 0.00
FitLife Brands (FTLF) United States $0.120B 0.00
Jin Medical (ZJYL) China $0.102B 0.00
Fonar (FONR) United States $0.092B 11.90
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Veru (VERU) United States $0.085B 0.00
Apyx Medical (APYX) United States $0.082B 0.00
Quipt Home Medical (QIPT) United States $0.078B 0.00
Zynex (ZYXI) United States $0.077B 0.00
Cytosorbents (CTSO) United States $0.077B 0.00
TerrAscend (TSNDF) Canada $0.077B 0.00
MacroGenics (MGNX) United States $0.075B 0.00
InterCure (INCR) Israel $0.068B 0.00
Agape ATP (ATPC) $0.066B 0.00
ImmuCell (ICCC) United States $0.061B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
Nephros (NEPH) United States $0.041B 55.14
United-Guardian (UG) United States $0.037B 12.94
Modular Medical (MODD) United States $0.037B 0.00
Rockwell Medical (RMTI) United States $0.027B 0.00
Safety Shot (SHOT) United States $0.023B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
INLIF (INLF) $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Senestech (SNES) United States $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00